Showing 2,901 - 2,920 results of 21,030 for search '"multiplication"', query time: 0.09s Refine Results
  1. 2901
  2. 2902
  3. 2903
  4. 2904
  5. 2905
  6. 2906
  7. 2907
  8. 2908
  9. 2909
  10. 2910

    Buffer-aided cooperative NOMA with power transfer by Long YANG, Li ZHAO, Yuchen ZHOU, Bingtao HE, Jian CHEN

    Published 2023-06-01
    Subjects: “…cooperative non-orthogonal multiple access…”
    Get full text
    Article
  11. 2911
  12. 2912
  13. 2913
  14. 2914
  15. 2915

    A multi-country cohort database study to assess pregnancy and infant outcomes after potential maternal or paternal exposure to cladribine tablets in the treatment of multiple sclerosis: the CLEAR study methods and status update by Kerstin Hellwig, Melinda Magyari, Thomas M. MacDonald, Carolyn E. Cesta, Stig Wergeland, Maarit K. Leinonen, Asher Ornoy, Sandra Vukusic, Alexandra Lauer, Xiaolei Zhou, Alison Kawai, Rachel Weinrib, Alejandro Arana, Tahani Boumenna

    Published 2025-01-01
    “…Four cohorts are included: pregnancies of women with multiple sclerosis (MS) exposed to cladribine tablets (maternal cohort exposed); pregnancies of women with MS unexposed to any disease-modifying therapy (DMT; maternal cohort unexposed); pregnancies fathered by men with MS exposed to cladribine tablets; and pregnancies fathered by men with MS unexposed to any DMT. …”
    Get full text
    Article
  16. 2916

    Élaboration d’un cadre de référence pour l’étude des stratégies : analyse de l’activité et étude de cas multiples dans deux usines de crabe by Marie-Eve Major, Nicole Vézina

    Published 2011-11-01
    “…Based on a methodology combining the ergonomic approach of work activity analysis and a multiple case study of 16 female workers (8 in Newfoundland, 8 in Quebec), interviews and observations of the work activity and organization were conducted for two consecutive years. …”
    Get full text
    Article
  17. 2917
  18. 2918

    Severe Late-Onset Drug-Induced Immune Thrombocytopenia Following IFN β-1a Treatment: A Case Report of a 52-Year-Old Woman with Relapse-Remitting Multiple Sclerosis by Christophe Cisarovsky, Marie Théaudin, Pierre-Alexandre Bart, Grégoire Stalder, Lorenzo Alberio

    Published 2022-01-01
    “…Interferon β-1a (IFNβ1a) is considered safe in relapsing-remitting multiple sclerosis (RRMS). Drug-induced thrombocytopenia (DITP) is a rare but underreported adverse event that is often confused with other causes of thrombocytopenia. …”
    Get full text
    Article
  19. 2919
  20. 2920